Abstract:Objective To investigate the effect of dimethyl fumarate on renal function and oxidative stress in calcium oxalate stone-forming rats by focusing on p38 mitogen-activated protein kinase (MAPK) pathway.Methods Thirty SPF male SD rats were randomly divided into control group, model group and dimethyl fumarate group. The rats in model group and dimethyl fumarate group were calcium oxalate stone formers. Rats in the dimethyl fumarate group were given intraperitoneal injection of dimethyl fumarate at a dose of 25 mg/(kg·d) for consecutive 28 days, while those in the control group and the model group were given intraperitoneal injection of the same amount of normal saline at the same time. The levels of urine protein, urine calcium and blood creatinine were detected by automatic biochemical analyzer, and the formation of calcium oxalate crystals in the rat kidney was observed by HE staining. The activity of superoxide dismutase (SOD), the content of malondialdehyde (MDA) and the level of reactive oxygen species (ROS) in the serum were determined by corresponding kits, and the level of proteins associated with the p38 MAPK pathway was detected by Western blotting.Results Compared with the control group, SOD activity in the kidney of rats in the model group and dimethyl fumarate group were decreased, while the contents of the calcium oxalate crystal content, urine protein, urine calcium, blood creatinine, and the levels of MDA, ROS, p-JNK, and p-p38 proteins in the kidney of rats in the model group and dimethyl fumarate group were increased (P < 0.05). In addition, SOD activity in renal tissues of rats in the dimethyl fumarate group were higher than those in the model group (P < 0.05), whereas the levels of calcium oxalate crystal content, urine creatinine, urine protein, urine calcium, blood creatinine, and the levels of MDA, ROS, p-JNK, and p-p38 proteins in the kidney of rats in the dimethyl fumarate group were lower than those in the model group (P < 0.05).Conclusions Dimethyl fumarate may protect renal function by inhibiting the activation of p38 MAPK pathway, oxidative stress, and calcium oxalate stone formation in the kidney.